Paul W. Hoelscher - 04 Jan 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role
EVP, CFO
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
04 Jan 2022
Net transactions value
-$5,159,825
Form type
4
Filing time
06 Jan 2022, 19:58:57 UTC
Previous filing
30 Dec 2021
Next filing
24 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise +66,822 +6370% 67,871 05 Jan 2022 Direct F1
transaction HZNP Ordinary Shares Award $0 +47,375 +70% $0.000000 115,246 05 Jan 2022 Direct F2
transaction HZNP Ordinary Shares Tax liability $5,159,825 -50,666 -44% $101.84 64,580 05 Jan 2022 Direct
holding HZNP Ordinary Shares 178,839 04 Jan 2022 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Restricted Stock Units (RSU) Award $0 +9,522 $0.000000 9,522 04 Jan 2022 Ordinary Shares 9,522 Direct F1, F3
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -17,983 -100% $0.000000* 0 05 Jan 2022 Ordinary Shares 17,983 Direct F1, F4
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -14,514 -50% $0.000000 14,514 05 Jan 2022 Ordinary Shares 14,514 Direct F1, F5
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -11,067 -50% $0.000000 11,069 05 Jan 2022 Ordinary Shares 11,067 Direct F1, F6
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -11,616 -67% $0.000000 5,800 05 Jan 2022 Ordinary Shares 11,616 Direct F1, F7
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -11,642 -33% $0.000000 23,286 05 Jan 2022 Ordinary Shares 11,642 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents a contingent right to receive one ordinary share of the Issuer.
F2 On January 5, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 5, 2022, the PSUs vested as to the number of shares reported above.
F3 The RSU's vest 1/3rd annually on each anniversary of January 5, 2022.
F4 The RSU's vest 1/3rd annually on each anniversary of January 5, 2019.
F5 The RSU's vest 1/3rd annually on each anniversary of January 5, 2020.
F6 50% of the shares subject to the RSU's vested on 1/5/2022, and the remaining shares vest on 1/5/2023.
F7 Two-thirds of the ordinary shares subject to the RSUs vest on January 5, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2023.
F8 The RSU's vest 1/3rd annually on each anniversary of January 5, 2021.